Janovec, V., Hodek, J., Clarova, K., Hofman, T., Dostalik, P., Fronek, J., . . . Weber, J. (2020). Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes. Nature Portfolio.
Chicago Style (17th ed.) CitationJanovec, Vaclav, et al. Toll-like Receptor Dual-acting Agonists Are Potent Inducers of PBMC-produced Cytokines That Inhibit Hepatitis B Virus Production in Primary Human Hepatocytes. Nature Portfolio, 2020.
MLA (8th ed.) CitationJanovec, Vaclav, et al. Toll-like Receptor Dual-acting Agonists Are Potent Inducers of PBMC-produced Cytokines That Inhibit Hepatitis B Virus Production in Primary Human Hepatocytes. Nature Portfolio, 2020.
Warning: These citations may not always be 100% accurate.